Research Topics
Genomes and Genes | Eric DeutschSummaryAffiliation: Institut Gustave Roussy Country: France Publications
| Collaborators
|
Detail Information
Publications
Environmental, genetic, and molecular features of prostate cancerEric Deutsch
Laboratoire UPRES EA 27 10, Institut Gustave Roussy, Villejuif, France
Lancet Oncol 5:303-13. 2004..This transition also signals a substantial worsening of prognosis. Here, we review the most important findings in prostate carcinogenesis and the molecular anomalies associated with the androgen-refractory stage...
Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylationE Deutsch
Laboratoire UPRES EA No 27 10, Radiosensibilite des tumeurs et tissus sains, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
Br J Cancer 91:1735-41. 2004..Therefore, these data suggest that Tyrphostin AG1024 could represent the basis of a novel therapy for STI571 refractory CML...
The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastropheYungan Tao
UPRES EA27 10 Laboratoire Radiosensibilité des Tumeurs et Tissus Sains, Villejuif, France
Cell Cycle 8:3172-81. 2009..Altogether, these data support the contention that AZD1152 mediates radiosensitization in vivo by enhancing mitotic catastrophe, which can be used as a biomarker of treatment efficacy...
[Cell cycle, mitosis and therapeutic applications]Antonin Levy
Institut Gustave Roussy, Service de radiothérapie oncologie, Universite Paris XI, Villejuif, France
Bull Cancer 98:1037-45. 2011..Promising preliminary data render these proteins potential targets for therapeutic development against cancer...
Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation responseYohann Loriot
UPRES 27 10, Institut Gustave Roussy, Villejuif, France
Anticancer Res 30:3869-78. 2010..The present study evaluated the efficacy of combining BCL-2 ODN and radiation in small-cell lung cancers (SCLC) cell lines...
Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combinationPierre Mordant
UPRES 2710, Universite Paris XI, Institut Gustave Roussy, Villejuif, 94805 France
Mol Cancer Ther 9:358-68. 2010..The combination of RAF and mTOR inhibitors is effective for enhancing antitumoral effects in cells with deregulation of both RAS-RAF and PI3K, possibly through the cross-inhibition of 4E binding protein 1 and S6 protein...
Minimal residual disease in solid neoplasia: New frontier or red-herring?Pierre Mordant
Institut Gustave Roussy, Universite Paris, Villejuif, France
Cancer Treat Rev 38:101-10. 2012....
Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasionAlexandre Kaliski
, Villejuif, France
Mol Cancer Ther 4:1717-28. 2005..This model could provide in vivo evidence of the antitumor efficacy of combining a MMP inhibitor with ionizing radiation to target radiation-induced invasion and angiogenesis...
The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trialsNicolas Magne
Department of Radiotherapy, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94 805 Villejuif, France
Eur J Cancer 44:2133-43. 2008..Here we report all the different published clinical trials focusing on efficacy and toxicity in order to clarify and to summarise the present state-of-the-art of this particularly promising combination in solid tumour management...
Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agentsNicolas Magne
Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
Cancer Metastasis Rev 27:737-50. 2008....
Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cellsPierre Mordant
INSERM U1030 and Université Paris XI, Institut Gustave Roussy, Villejuif, France
PLoS ONE 6:e26073. 2011..We sought to compare and refine bioluminescent orthotopic mouse models of human localized NSCLC...
Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpointsYungan Tao
UPRES EA27 10 Laboratoire Radiosensibilité des Tumeurs et Tissus Sains, University Paris Sud XI Kremlin Bicêtre and Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France
Cell Cycle 8:1196-205. 2009..Altogether these results suggest that Chir-124-mediated radiosensitization is profoundly influenced by the p53 and cell cycle checkpoint system...
Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapyYohann Loriot
Institute Gustave Roussy, Villejuif, France
Nat Clin Pract Oncol 5:268-78. 2008..We review the incidence and clinical patterns of the gastrointestinal and hepatic toxic effects induced by the main molecular-targeted therapies and propose some hypotheses for the causes of each adverse event...
Are RAS mutations predictive markers of resistance to standard chemotherapy?Yohann Loriot
SITEP, Department of Medicine, University Paris XI, Institut Gustave Roussy, Villejuif, France
Nat Rev Clin Oncol 6:528-34. 2009..Therefore, KRAS mutations should not be used as molecular predictors of response to conventional chemotherapy...
Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenograftsCyrus Chargari
Radiothérapie moléculaire, Universite Paris XI, Institut Gustave Roussy, Villejuif, France
Cancer Lett 312:209-18. 2011..Further investigations are warranted with regard to the molecular mechanisms underlying its actions and its dependency regarding p53 status...
Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cellsBixiu Wen
UPRES EA No 27 10, Radiosensibilité des tumeurs et des tissues sains, Institut Gustave Roussy, 94805 Villejuif Cedex, France
J Urol 170:2036-9. 2003..We examined the potential therapeutic effect of NS398, a selective cyclooxygenase-2 (COX-2) inhibitor, combined with irradiation on human prostate adenocarcinoma DU145 cells...
Oncologic and functional results after abdominoperineal resection plus pseudocontinent perineal colostomy for epidermoid carcinoma of the anusDiane Goere
Department of Surgical Oncology, Institut Gustave Roussy, Cancer Center, Villejuif, France
Dis Colon Rectum 52:958-63. 2009....
Sensitivity to radiation and alkylating agent of peripheral lymphocytes and fibroblasts in a Hoyeraal-Hreidarsson syndrome patientRadhia M'kacher
Service de Pediatrie, Centre Hospitalier Universitaire de Besancon, Bescancon, France
Pediatr Hematol Oncol 20:651-6. 2003..The data suggest that conditioning regimens including TBI should not be used when a bone marrow transplantation procedure is planned in these patients...
[Anti-apoptotic mechanisms in small-cell lung carcinoma]Yohann Loriot
Departement de Medecine, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France
Ann Pathol 30:17-24. 2010..New therapies targeting some of these abnormalities are under clinical evaluation and predictive factors of response are needed to personalize these therapies...
Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cellsAbdessamad Amine
Laboratoire UPRES EA 27 10 Radiosensibilité des Tumeurs et Tissus Sains, Institut Gustave Roussy Institut de Radioprotection et de Sureté Nucléaire, Villejuif, France
PLoS ONE 4:e5018. 2009..These data suggest a novel and highly translatable therapeutic approach to cervix cancer, by inhibition of adhesion and invasion of circulating HPV-positive tumor cells, using Cidofovir and/or ROCK inhibition...
Lung cancer stem cell: new insights on experimental models and preclinical dataCaroline Rivera
Laboratoire UPRES EA 27 10 Radiosensibilité des Tumeurs et Tissus Sains, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France
J Oncol 2011:549181. 2011..Preclinical data on putative CSC targets are emerging by now. These preliminary studies are critical for the next generation of lung cancer therapies...
Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivityMarie Catherine Vozenin
UPRES EA 27 10 Radiosensibilité des tumeurs et tissus sains, Institut Gustave Roussy, Villejuif, France
Cancer Treat Rev 36:629-36. 2010....
Concomitant chemo-radiotherapy in clinical trials: to promote step by step rational developmentNicolas Magne
Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
Crit Rev Oncol Hematol 70:206-15. 2009..A caveat is directed at radiation oncologists, at the expense of scientific reliability and validity which surely, should not be compromised...
Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapyCéline Clémenson
INSERM U1030, Radiothérapie moléculaire, Institut Gustave Roussy, Universite Paris XI, Villejuif, France
Invest New Drugs 30:2173-86. 2012..This provides a good rationale to further assess EHT 6706 in combination protocols and confirm these effects in vivo...
Chemoprevention of lung cancerJean Charles Soria
Departement of Medicine, Institut Gustave Roussy, Villejuif, France
Lancet Oncol 4:659-69. 2003..Development of a risk model with intermediate endpoints is essential for future chemoprevention studies...
Current state of knowledge regarding the use of antiangiogenic agents with radiation therapyRenaud Mazeron
Radiation Oncology, Institut Gustave Roussy, Villejuif Cedex, France
Cancer Treat Rev 37:476-86. 2011..The objective of this article is to review the concept of targeted antiangiogenic agents and the early clinical results of their use in combination with radiation therapy...
Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protectionMonica Mangoni
Laboratoire UPRES EA 2710, Institut Gustave Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 74:1242-50. 2009....
Endothelial-cell apoptosis and tumour response to radiotherapyBassam Abdulkarim
Institut Gustave Roussy, Villejuif, France
Lancet Oncol 5:9. 2004
Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cellsEric Deutsch
Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France
Blood 101:4583-8. 2003..These findings reveal a novel link between the oncoprotein BCR-ABL and the tumor-suppressor protein BRCA1...
Gene expression profile in human late radiation enteritis obtained by high-density cDNA array hybridizationMarie Catherine Vozenin-Brotons
Laboratoire UPRES EA 27 10 Radiosensibilité des Tumeurs et Tissus Sains, Institut Gustave Roussy Institut de Radioprotection et de Sureté Nucléaire, Villejuif, France
Radiat Res 161:299-311. 2004..e. the mucosa, the mesenchyme, and blood vessels. Functional studies will be necessary to validate the present results...
The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cureMichel Ducreux
Unité de Gastroentérologie, Departement de Medecine, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
Best Pract Res Clin Gastroenterol 21:997-1014. 2007..For advanced disease, chemotherapy alone has given very disappointing results. A multidisciplinary approach combining biological assessment of targets with clinical trials to evaluate new targeted drugs should be considered...
New concepts for phase I trials: evaluating new drugs combined with radiation therapyEric Deutsch
Radiation Oncology Department, University of Pennsylvania, Philadelphia, USA
Nat Clin Pract Oncol 2:456-65. 2005..It will be necessary to rethink phase I strategies, toxicity endpoints, and trial designs and concepts in order to fully optimize these regimens...
Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivityRemko Prevo
Radiobiology Research Institute, Oxford University, Oxford, United Kingdom
Cancer Res 68:5915-23. 2008..These results indicate that pharmacologic inhibitors with enhanced specificity for class I PI3K may be of benefit when combined with radiotherapy...
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignanciesBassam Abdulkarim
, France
Oncogene 22:2260-71. 2003..These results provide the basis for a novel anticancer strategy to enhance the therapeutic ratio of IR in EBV-related cancers...
Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivoLaurence Maggiorella
, 94805 Villejuif, Cedex, France
Cancer Res 63:2513-7. 2003..In conclusion, we found a novel effect on DNA repair of the CDK inhibitor roscovitine, which acts as a radiosensitizer in vitro and in vivo in breast cancer cells lacking a functional p53...
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancersBassam Abdulkarim
, Institut Gustave-Roussy, 94805 Villejuif, France
Oncogene 21:2334-46. 2002..This study provides the basis for a new anticancer strategy to enhance the antitumor effect of ionizing radiation in HPV-related cancers, without increase deleterious effects...
Design and implementation of microarray gene expression markup language (MAGE-ML)Paul T Spellman
Department of Cell and Molecular Biology, University of California at Berkeley, Berkeley, CA 94720 3206, USA
Genome Biol 3:RESEARCH0046. 2002..Only when data can be easily exchanged will the entire biological community be able to derive the full benefit from such microarray studies...
Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancerYungan Tao
Institute Gustave Roussy and the Department of Radiation Oncology of Cancer Hospital, Fu Dan University, Shanghai, China
Nat Clin Pract Oncol 4:591-602. 2007..This Review highlights the most relevant studies in this exciting area of research, focusing in particular on the role of IGF1R in resistance to other receptor-targeted therapies for cancer...
Essential role of plasminogen activator inhibitor type-1 in radiation enteropathyFabien Milliat
Laboratory of Radiopathology, Institute for Radiological Protection and Nuclear Safety, Fontenay aux Roses Unité Propre de Recherche et de l Enseignement Supérieur, Equipe d Accueil 2710, France
Am J Pathol 172:691-701. 2008..Together, these data demonstrate that PAI-1 plays a critical role in radiation-induced intestinal damage, suggesting that PAI-1 is an attractive target for preventing or reducing the side effects of radiation therapy...
Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma modelLaurence Maggiorella
, Institut Gustave-Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Anticancer Res 25:4357-62. 2005..These data suggested that Ritonavir could clinically improve the tumor response to radiation therapy, especially in head and neck carcinoma...
[Perspectives in biological modulation of radiotherapy]Eric Deutsch
, Institut Gustave-Roussy, 39 rue Camille-Desmoulin, 94805 Villejuif,
Bull Cancer 92:90-6. 2005..These approaches attempt to widen the therapeutic ratio of radiation, i.e. to increase specifically tumor radiation response with little impact on normal tissue response...
Radiosensitizing effects of the prenyltransferase inhibitor AZD3409 against RAS mutated cell linesKeith A Cengel
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Cancer Biol Ther 5:1206-10. 2006..Thus, radiosensitization of human cancer cells that express mutated K-RAS occurred under conditions where AZD3409 inihibits the activation of farneyslated H-RAS, but did not inhibit K-RAS activation...
Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damagesFabien Milliat
Laboratory of Radiopathology, Institute for Radiological Protection and Nuclear Safety IRSN, BP17, 92262 Fontenay aux Roses, France
Am J Pathol 169:1484-95. 2006..Moreover, we demonstrate in vitro that ECs influence these fundamental mechanisms involved in radiation-induced vascular damages...
